| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.08▲ | 1.08▲ | 1.09▼ | 1.12▼ | 1.22▼ |
| MA10 | 1.09▼ | 1.10▼ | 1.11▼ | 1.14▼ | 1.31▼ |
| MA20 | 1.12▼ | 1.13▼ | 1.13▼ | 1.22▼ | 1.37▼ |
| MA50 | 1.13▼ | 1.14▼ | 1.15▼ | 1.32▼ | 1.89▼ |
| MA100 | 1.14▼ | 1.18▼ | 1.23▼ | 1.39▼ | 3.56▼ |
| MA200 | 1.18▼ | 1.27▼ | 1.31▼ | 1.59▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.006▼ | -0.005▼ | -0.010▼ | 0.022▲ |
| RSI | 39.260▼ | 40.733▼ | 40.332▼ | 32.753▼ | 35.296▼ |
| STOCH | 27.778 | 14.935▼ | 12.889▼ | 30.239 | 33.189 |
| WILL %R | -81.250▼ | -87.500▼ | -87.500▼ | -87.037▼ | -92.045▼ |
| CCI | -50.767 | -62.848 | -74.222 | -128.914▼ | -186.463▼ |
|
Monday, December 29, 2025 04:00 PM
No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following oral administration. MIAMI, FL / ACCESS Newswire / December 18, 2025 / ...
|
|
Saturday, December 20, 2025 02:56 PM
MIAMI, FL / ACCESS Newswire / December 18, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), a preclinical-stage biotechnology company developing therapies that target ...
|
|
Thursday, December 11, 2025 12:59 PM
Toronto, Ontario--(Newsfile Corp. - December 11, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 1.07 | 1.09 | 1.07 | 1.085 | 65,096 |
| 12/02/26 | 1.13 | 1.16 | 1.05 | 1.08 | 182,500 |
| 11/02/26 | 1.17 | 1.17 | 1.12 | 1.12 | 105,582 |
| 10/02/26 | 1.18 | 1.20 | 1.15 | 1.17 | 51,619 |
| 09/02/26 | 1.15 | 1.1769 | 1.1101 | 1.16 | 74,383 |
| 06/02/26 | 1.11 | 1.19 | 1.11 | 1.15 | 120,082 |
| 05/02/26 | 1.17 | 1.20 | 1.07 | 1.12 | 300,859 |
| 04/02/26 | 1.17 | 1.19 | 1.12 | 1.16 | 113,825 |
| 03/02/26 | 1.20 | 1.22 | 1.15 | 1.18 | 102,265 |
| 02/02/26 | 1.13 | 1.2399 | 1.13 | 1.22 | 193,303 |
|
|
||||
|
|
||||
|
|